Development of Bifunctional Inhibitors of Polo‐Like Kinase 1 with Low‐Nanomolar Activities Against the Polo‐Box Domain - Scharow - 2016 - ChemBioChem - Wiley Online Library
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
Mitotic Roles of Polo Like Kinase
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
![PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33119311272773173c201b3d02ff3ad18b4a1955/2-Figure1-1.png "PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar")
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
p53-Dependent and Cell Specific Epigenetic Regulation of the Polo-like kinases under Oxidative Stress | PLOS ONE
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
PLK1 - Wikipedia
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models | Journal of Medicinal Chemistry
![The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]](https://www.thno.org/v11/p9571/toc.jpg "The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]")
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology
Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling | eLife
PLK-1 Inhibitors: New Treatment for MDS? - ppt download
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emergi | LCTT
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
